Showing 101 - 120 results of 49,761 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ((( 2 c decrease ) OR ( 50 ng decrease ))))', query time: 0.99s Refine Results
  1. 101
  2. 102

    Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

    Published 2020
    “…At the 25 min mark, 1.0 μM 12-TPP was added to treatment A375 cells followed by the sequential addition of 2.5 μM oligomycin at the 60 min mark, 0.3 μM oligomycin at the 90 min mark, and 5.0 μM rotenone/antimycin A at the 120 min mark. …”
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108

    Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

    Published 2021
    “…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117

    Hematopoietic-restricted loss of Zeb1 decreases hematopoietic colony formation potential and ability to compete with wt HSPCs for contribution to all hematopoietic lineages. by Jueqiong Wang (11467505)

    Published 2021
    “…<b>(C)</b> <i>Zeb1</i> null (Vav-iCre, <i>Zeb1</i><sup>fl/fl</sup>) CD45.2<sup>+</sup> donor cells (orange bars) were outcompeted by control CD45.1<sup>+</sup> competitor HSPCs (blue bars) for their ability to contribute to all hematopoietic cells analyzed in the PB and BM (rightmost panels). …”
  18. 118
  19. 119
  20. 120